Ergomed has announced changes to its board and management team with the appointment of Stephen Stamp as chief executive and Dr Jan Petracek as chief operating officer with immediate effect.
Dr Dan Weng has decided to step down as CEO.
Stamp has been Ergomed's chief financial officer since January 2016.
Petracek has been CEO of Ergomed's pharmacovigilance subsidiary PrimeVigilance, since April, having joined the Company in November 2016 following the acquisition of European PharmInvent Services where he was CEO.
Chairman Peter George said: 'Stephen has exceptionally wide business experience and has developed a deep understanding of Ergomed and its markets.
'His move to CEO makes strong strategic sense as the company looks to continue to deliver on its strategy. I am also delighted to have Jan join the Board as COO.
'He has added significant value to the executive management team since joining Ergomed in 2016 and his vision and drive has contributed substantially to our pharmacovigilance business which continues to significantly outpace the growth of a fast growing market.
'We look forward to his contribution across our wider services business and the company as a whole.
'I'd like to thank Dan for his contributions this year and wish him well with his future endeavours.'
At 9:19am: (LON:ERGO) Ergomed Plc share price was 0p at 187.5p